Loading clinical trials...
Loading clinical trials...
Semaglutide for the Treatment of Opioid Use Disorder: A Pilot Randomized Controlled Trial
Conditions
Interventions
Semaglutide
Placebo
Locations
1
United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Start Date
June 2, 2025
Primary Completion Date
August 31, 2026
Completion Date
August 31, 2026
Last Updated
September 26, 2025
NCT06651177
NCT06843213
NCT05995886
NCT07044466
NCT07350148
NCT06585709
Lead Sponsor
Brigham and Women's Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions